Related references
Note: Only part of the references are listed.Platinum complexes can inhibit matrix metalloproteinase activity: Platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12
Rossella Sasanelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The first ruthenium-based paullones: Syntheses, X-ray diffraction structures, and spectroscopic and antiproliferative properties in vitro
Wolfgang F. Schmid et al.
INORGANIC CHEMISTRY (2007)
Gallium(III) and Iron(III) complexes of α-N-heterocyclic thiosemicarbazones:: Synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase
Christian R. Kowol et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor
Nicola Margiotta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate
Meiying Yang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands
Stefanie Zorbas-Seifried et al.
MOLECULAR PHARMACOLOGY (2007)
Transplatin is cytotoxic when photoactivated: Enhanced formation of DNA cross-links
Pavla Heringova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A third mode of DNA binding: Phosphate clamps by a polynuclear platinum complex
Seiji Komeda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition
Christopher R. Chitambar et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy
Wee Han Ang et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2006)
Interactions of platinum complexes containing cationic, bicyclic, nonplanar piperidinopiperidine ligands with biological nucleophiles
Yousef Najajreh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer
Thomas A. Hensing et al.
ANTI-CANCER DRUGS (2006)
Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells
Vivek Barve et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding
Stephane Teletchea et al.
CHEMISTRY-A EUROPEAN JOURNAL (2006)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: Identification of novel intermediates
NP Davies et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The first metal-based paullone derivative with high anti proliferative activity in vitro
A Dobrov et al.
INORGANIC CHEMISTRY (2006)
Synthesis and in vitro antitumor activity of platinum acetonimine complexes
A Boccarelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Redox behavior of tumor-inhibiting ruthenium(III) complexes and effects of physiological reductants on their binding to GMP
P Schluga et al.
DALTON TRANSACTIONS (2006)
Ruthenium half-sandwich complexes bound to protein kinase Pim-1
JE Debreczeni et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology
Andrei R. Timerbaev et al.
CHEMICAL REVIEWS (2006)
Tuning of redox properties for the design of ruthenium anticancer drugs:: Part 2.: Syntheses, crystal structures, and electrochemistry of potentially antitumor [RuIII/IICl6-n(Azole)n]z (n=3, 4, 6) complexes
E Reisner et al.
INORGANIC CHEMISTRY (2005)
Platinum complexes with the novel ligand diethyl [(methylsulfinyl)methyl]phosphonate (SMP): Solid-state characterization of potassium trichloro(SMP)platinum(II) which, in solution, gives dichloro(SMP)-platinum(II) and potassium chloride
M Laforgia et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2005)
Redox-active antineoplastic ruthenium complexes with indazole: Correlation of in vitro potency and reduction potential
MA Jakupec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Free exchange across cells, and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A (imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate) on KB tumor cells
F Frausin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Synthesis and in vitro antitumor potency of (cyclohexane-1,2-diamine)platinum(II) complexes with aminotris(methylenephosphonic acid) as bone-seeking ligand
M Galanski et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2005)
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
S Kapitza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)
T Latif et al.
INVESTIGATIONAL NEW DRUGS (2005)
Reactions of potent antitumor complex trans-[RuIIICl4(indazole)2]-with a DNA-relevant nucleobase and thioethers:: Insight into biological action
A Egger et al.
INORGANIC CHEMISTRY (2005)
Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles
H Cabral et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Update of the preclinical situation of anticancer platinum complexes: Novel design strategies and innovative analytical approaches
M Galanski et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes
E Gabano et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan et al.
CHEMICAL COMMUNICATIONS (2005)
Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes
W Friebolin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure
A Hegmans et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Synthesis and characterization of platinum(II) complexes of diethyl [(methylsulfinyl)methyl]phosphonate: Potential drugs against bone tumors
M Laforgia et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2004)
Synthesis, crystal structure and pH dependent cytotoxicity of (SP-4-2)-bis(2-aminoethanolato-κ2N, O)platinum(II) -: a representative of novel pH sensitive anticancer platinum complexes
MS Galanski et al.
INORGANICA CHIMICA ACTA (2004)
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment
S Pacor et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesopliageal adenocarcinoma
DI Jodrell et al.
EUROPEAN JOURNAL OF CANCER (2004)
Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines
D Pluim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy
M Pongratz et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2004)
Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs
A Warnecke et al.
BIOCONJUGATE CHEMISTRY (2004)
Tuning of redox potentials for the design of ruthenium anticancer drugs -: An electrochemical study of [trans-RuCl4L(DMSO)]- and [trans-RuCl42]- complexes, where L = imidazole, 1,2,4-triazole, indazole
E Reisner et al.
INORGANIC CHEMISTRY (2004)
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A
G Sava et al.
EUROPEAN JOURNAL OF CANCER (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Gallium compounds as antineoplastic agents
CR Chitambar
CURRENT OPINION IN ONCOLOGY (2004)
A phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Platinum(II) and technetium(I) complexes anchored to ethynylestradiol:: a way to drug targeting and delivery
C Cassino et al.
INORGANICA CHIMICA ACTA (2004)
Gallium in cancer treatment
MA Jakupec et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Hypoxia as a factor for Ga-67 accumulation in tumour cells
S Kinuya et al.
NUCLEAR MEDICINE COMMUNICATIONS (2004)
Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents
R Cini et al.
INORGANIC CHEMISTRY (2003)
DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2].: A concept for activation of the trans geometry in platinum antitumor complexes
O Novakova et al.
NUCLEIC ACIDS RESEARCH (2003)
Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand
M Galanski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group:: Selective synthesis by McMurry coupling, and biochemical behaviour
S Top et al.
CHEMBIOCHEM (2003)
Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates
A Furin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Iron chelators as anti-neoplastic agents: Current developments and promise of the PIH class of chelators
DB Lovejoy et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Tumor-inhibiting platinum(II) complexes with aminoalcohol ligands: Comparison of the mode of action by capillary electrophoresis and electrospray ionization-mass spectrometry
CG Hartinger et al.
ELECTROPHORESIS (2003)
Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies
O Aronov et al.
BIOCONJUGATE CHEMISTRY (2003)
Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds
R Paschke et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Gallium nitrate in multiple myeloma: Prolonged survival in a cohort of patients with advanced-stage disease
R Niesvizky
SEMINARS IN ONCOLOGY (2003)
Recent developments in the field of tumor-inhibiting metal complexes
M Galanski et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine 4N-dimethylthiosemicarbazone
VB Arion et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Gallium in cancer treatment
P Collery et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
A Vacca et al.
BRITISH JOURNAL OF CANCER (2002)
A new antimetabolite, 5-morpholinomethyl-2-thiouracil - spectral properties, thermal profiles, antibacterial, antifungal and antitumour studies of some of its metal chelates
P Kamalakannan et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2002)
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator
RD Abeysinghe et al.
CARCINOGENESIS (2001)
Investigations into the interaction between tumor-inhibiting ruthenium(III) complexes and nucleotides by capillary electrophoresis
A Küng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2001)
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(lll) in cell-free media
J Malina et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2001)
2-substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity
C Kunick et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Structural characterization, kinetic studies, and in vitro biological activity of new cis-diamminebis-cholylglycinate (O,O′) Pt(II) and cis-diamminebis-ursodeoxycholate(O,O′) Pt(II) complexes
JJ Criado et al.
BIOCONJUGATE CHEMISTRY (2000)
Share Paper
